Most progress in cancer treatment by Novartis/Mariana by end of 2024 | Categorical | | | 8 months ago | |
Integration status of Mariana Oncology into Novartis by May 2024 | Categorical | | | 8 months ago | |
Novartis achieves clinical milestone with Mariana's drug by May 2024? | Binary | | | 8 months ago | |
Regulatory setback for Novartis/Mariana by May 2024? | Binary | | | 8 months ago | |
Impact on Novartis stock price by end of 2024 | Categorical | | | 8 months ago | |
Will Judo Bio secure additional funding by October 2025? | Binary | | | 3 months ago | |
Will Judo Bio partner with a major pharma company by October 2025? | Binary | | | 3 months ago | |
How many RNA drugs will Judo Bio develop using STRIKE by 2027? | Categorical | | | 3 months ago | |
What will be Kailera Therapeutics' market valuation by December 31, 2024? | Categorical | | | 3 months ago | |
Will Kailera Therapeutics raise additional funding by June 30, 2024? | Binary | | | 3 months ago | |
In which quarter of 2024 will Kailera Therapeutics release its first obesity treatment to the market? | Categorical | | | 3 months ago | |
Will GRO Biosciences announce a major pharmaceutical partnership by end of 2024? | Binary | | | 5 months ago | |
Will GRO Biosciences secure another funding round by July 19, 2025? | Binary | | | 5 months ago | |
What will be the valuation of GRO Biosciences by end of 2024? | Categorical | | | 5 months ago | |
Novartis increases market share in radiopharmaceuticals by end of 2024? | Binary | | | 8 months ago | |
What will be Judo Bio's major clinical milestone by end of 2026? | Categorical | | | 3 months ago | |
Will Judo Bio complete Phase 1 trial for RNA kidney drug by end of 2025? | Binary | | | 3 months ago | |
When will Judo Bio's first kidney RNA drug reach the market? | Categorical | | | 3 months ago | |
Will Kailera Therapeutics secure FDA approval for its first obesity treatment by December 31, 2024? | Binary | | | 3 months ago | |
Will Kailera Therapeutics announce a commercial manufacturing deal by March 31, 2024? | Binary | | | 3 months ago | |
In which quarter will Kailera Therapeutics announce its first major acquisition? | Categorical | | | 3 months ago | |
Will GRO Biosciences initiate a clinical trial for NSAA-based therapy by end of 2024? | Binary | | | 5 months ago | |
How many new NSAA-based therapies will GRO Biosciences add to its pipeline by July 19, 2025? | Categorical | | | 5 months ago | |
What will be the outcome of GRO Biosciences' lead NSAA-based therapy preclinical trials by end of 2024? | Categorical | | | 5 months ago | |
